Immunotherapy

A first-in-human clinical trial will assess the safety of a personalized vaccine to treat diffuse hemispheric glioma, an aggressive brain tumor.

Patients who received chimeric antigen receptor T-cell therapy did not exhibit increased risk for second primary malignancies compared with those who received other standard treatments, according to a systematic review and meta-analysis.

Immunotherapy before and after surgery significantly improved EFS compared with neoadjuvant immunotherapy only for patients with resectable non-small cell lung cancer, according to a comparison of results from two randomized phase 3 trials.

City of Hope will host Society for Integrative Oncology’s 21st International Conference from Oct. 25-27.

As fall draws near, so does the season for viruses and environmental allergens, which can trigger asthma. Experts say that with children returning to school and the season changing, allergists can expect to see an increase in patients.

The Global Allergy and Asthma Excellence Network, or GA2LEN, will host its biannual global meeting from Sept. 5 to 7.

Healio has compiled August’s most-read news in asthma and allergy.

A novel therapeutic approach stimulated new and existing T-cell responses among patients with melanoma or non-small cell lung cancer, according to results of a phase 1 trial.

SAN ANTONIO — Tricia Sowers, PhD, introduced attendees to allergenic trees along the River Walk and discussed how immunotherapy can address them at the 16th Annual Allergy, Asthma & Immunology CME Conference.

During a shareholder presentation in front of more than 500 physicians in April, Debra A. Patt, MD, PhD, MBA, FASCO, asked how many in attendance used large language models like ChatGPT and Claude.